Abstract
Background
Stroke burden characterization studies in low‐ and middle‐income countries are scarce. We estimated the burden of stroke and its risk factors in Latin America and the Caribbean (LAC).
Methods and Results
We extracted GBD (Global Burden of Disease) study 2019 data on overall stroke and 3 subtypes (ischemic stroke, intracerebral hemorrhage, and subarachnoid hemorrhage) for 20 LAC countries. We estimated absolute and age‐standardized rates of disability‐adjusted life years, years of life lost, years lived with disability, and deaths. The population‐attributable fractions of 17 risk factors were estimated. All analyses were performed at regional and national levels by stroke subtype, sex, and age subgroups. In 2019, the LAC region had the fourth largest stroke burden worldwide (6.8 million disability‐adjusted life years), predominantly attributable to premature deaths (89.5% of disability‐adjusted life years). Intracerebral hemorrhage was the primary cause of the overall stroke burden (42% of disability‐adjusted life years), but ischemic stroke was the leading cause of disability (69% of total years lived with disability). Haiti and Honduras had the highest age‐standardized rates. Older adults and men had the largest burdens, although women had the highest rate of disability. Socioeconomic development level did not influence the burden. The major risk factor clusters were metabolic (high systolic blood pressure [population‐attributable fraction=53%] and high body mass index [population‐attributable fraction=37%]), which were more influential in hemorrhagic events, women, and older adults. Household air pollution was an important risk factor in low‐income countries in LAC.
Conclusions
The stroke burden and stroke‐related mortality in LAC are higher than the worldwide averages. However, stroke is a highly preventable disease in this region. Up to 90% of the burden could be reduced by targeting 2 modifiable factors: blood pressure and body mass index. Further research and implementation of primary and secondary prevention interventions are needed, as well as integrated national stroke care programs for acute, subacute, and rehabilitation management in LAC.
Keywords: GBD (Global Burden of Disease) study, risk factors, stroke
Subject Categories: Epidemiology, Cerebrovascular Disease/Stroke
Nonstandard Abbreviations and Acronyms
- PAF
population‐attributable fraction
- SBP
systolic blood pressure
- SDI
sociodemographic index
- YLLs
years of life lost
Clinical Perspective.
What Is New?
For the first time, we systematically assessed the burden of stroke in Latin America and the Caribbean, showing that the burden is high, representing the fourth highest burden worldwide.
Hemorrhagic stroke had the largest burden in Latin America and the Caribbean (measured in disability‐adjusted life years and years of life lost), but ischemic stroke was responsible for more disability (years lived with disability) and a larger number of absolute deaths.
What Are the Clinical Implications?
Most of the burden (up to 90%) could be reduced by controlling high systolic blood pressure (53%) and body mass index (37%), which are highly preventable risk factors.
Stroke is the second leading cause of death and the third leading cause of disability worldwide, following heart disease. 1 , 2 In 2016, 5.5 million individuals died, 3 whereas one‐third of stroke survivors required some type of poststroke care. 4 The direct annual costs of stroke care in the United States have been reported to be $34 billion. 5
In recent years, the major contributors to the global burden of stroke have transitioned from predominantly developed countries to other regions, such as Latin America and the Caribbean (LAC). In 2017, the number of deaths attributable to stroke in LAC was estimated to be ≈26 million, whereas the number of survivors with potential disabilities was 5.5 million. 1 However, the epidemiological impact of stroke and its risk factors at the regional and national levels remains unknown.
When assessing the consequences of stroke, the classic metrics of morbidity (prevalence and incidence), mortality, and cost measurements are insufficient. Those do not represent the magnitude of the disability produced by the loss of health, limiting a proper depiction of the implications for health systems. 6 Instead, the burden of disease can be estimated using the metrics of disability‐adjusted life years (DALYs), years of life lost (YLLs), and years lived with disability (YLDs). 7 The burden of disease can be understood as the loss of opportunity to live a healthy life without disabilities or a premature death. 8 These composite evaluations are more relevant for highly disabling and fatal conditions, such as stroke. This analysis is also context dependent and is affected by regional factors. Hence, regional and local estimations are needed to improve health care management, to identify prevalent modifiable risk factors, and to guide public health policies, especially in limited resource settings, such as LAC. Nevertheless, studies on stroke burden in LAC are scarce.
This study aims to assess the burden of stroke and its risk factors in LAC by analyzing GBD (Global Burden of Disease) 2019 study data 9 ; evaluating the burden by country, sex, age, and stroke type; and assessing the population‐attributable fractions (PAFs) of 17 risk factors.
METHODS
This study used open‐access GBD study 2019 platform data that were collected from country‐level surveillance, populational meta‐analyses, and indirect statistical estimations. 10 All the data used in this article are freely accessible after registration for the GBD study 2019 result tool (https://vizhub.healthdata.org/gbd‐results/). Additional information from our results is available on request from the corresponding author. Because all of the data included were aggregated and nonidentified, this study was exempted from institutional review board evaluation.
Stroke Definition
Stroke was defined as “rapidly developed clinical signs of focal (or global) disturbance of cerebral function, lasting more than 24 hours or leading to death, with no apparent cause other than of vascular origin.” 11
LAC Countries
We analyzed 20 countries from the LAC region with data available in the GBD study. 12 , 13 We included the following mainland countries: Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, Ecuador, El Salvador, Guatemala, Honduras, Mexico, Nicaragua, Panama, Paraguay, Peru, Uruguay, and Venezuela. In addition, we included 3 representative Caribbean islands: Cuba, Dominican Republic, and Haiti. Data from the rest of the Caribbean were scarce and mostly calculated by predictive modeling, so they were not included in our analysis.
GBD Study 2019
The methods of the GBD study 2019 have been described previously. 10 Their estimations were conducted using Bayesian meta‐regression modeling (with DisMod‐MR 2.1 software). The data were retrieved from population surveys and systematic reviews with meta‐analyses available from areas and countries worldwide. Predictive estimations were conducted for countries with sparse or no data.
GBD Study Metrics
The GBD study provides new metrics adjusted for possible confounders. 14 The metrics included in this study are as follows.
Years of Life Lost
YLLs are calculated by multiplying of the number of deaths per age group by the remaining years to live, according to GBD study standard life‐expectancy values. 15
Years Lived With Disability
YLDs are defined as “the number of incident cases in a certain period of time multiplied by the average of disease duration and by a weight factor that reflects its severity, which ranges from 0 (perfect health) to 1 (deceased).” 16
Disability‐Adjusted Life Years
DALYs are calculated by summing the years of life lost because of premature mortality (YLL) and the years of healthy life lost because of disability. 16
PAF of a Risk Factor
In summary, the PAF was estimated using data for exposure, relative risk, and the theoretical‐minimum risk exposure level. This metric is interpreted as the degree of burden (expressed in percentage) explained by a certain risk factor. For systolic blood pressure (SBP), the risk was modeled considering 10 mm Hg above the theoretical‐minimum risk exposure level (115 mm Hg). High body mass index (BMI) was defined as >20 to 25 kg/m2 for adults and as obesity or overweight in children according to the International Obesity Task Force standards. The rest of the methods for the calculation of the risk factors and their definitions have been published previously. 17
Risk Factors
We analyzed 17 factors grouped into 3 clusters 18 :
Behavioral: smoking (including second‐hand smoking), diet (diet high in sodium, diet high in sugar‐sweetened beverages, diet low in fruits, diet low in vegetables, diet low in whole grains, and alcohol consumption), and low physical activity.
Environmental and occupational: ambient particulate matter pollution, household air pollution, and lead exposure.
Metabolic: high BMI, high fasting plasma glucose, high SBP, high total cholesterol, and low glomerular filtration rate.
The ranking of the risk factors was based on the percentage of the absolute number of DALYs that were explained by the risk factor and ranked in descending order.
Sociodemographic Index
The sociodemographic index (SDI) was calculated as a composite of the income per capita, the years of school education, and the fertility rate in women aged <25 years. 14
A summary of the definitions of these metrics is presented in able S1 through S5.
Data Extraction Procedure
All the information was downloaded from the GBD study 2019 open‐access website (http://ghdx.healthdata.org/gbd‐results‐tool) and extracted independently by 2 researchers (KPB and SGL). For location, we selected the global values and the LAC countries mentioned above. LAC values were obtained by adding the value from all the included countries and not from the default data set, which excludes Argentina and Uruguay. We downloaded data for DALYs, YLDs, YLLs, and deaths in absolute values as well as by age‐standardized rates (per 100 000 habitants); for overall stroke and by subtype (ischemic stroke, intracerebral hemorrhage, and subarachnoid hemorrhage); and by country and sex (women, men, and both). Furthermore, we chose the following age intervals: <5, 5 to 14, 15 to 49, 50 to 69, and ≥70 years and all ages. Interval values were added to create the <50 and >50 years subgroups. Finally, we classified LAC countries by income as presented in the GBD study platform (high, upper‐middle, lower‐middle, and low income) and extracted the SDI value per country. The data, tables, and figures were processed with Microsoft Excel v.16.35.
Statistical Analysis
For the descriptive analysis, the number, rates, and their 95% uncertainty intervals (UIs) were included. The UIs were generated for every metric using the 25th and 975th ordered 1000 draw values of the posterior distribution. We included the age‐standardized rates, which account for only corrections on the participants' age. Sex differences were analyzed separately. We performed an exploratory analysis of the correlation between the burden metrics (DALYs, YLDs, and YLLs) and the countries' SDIs. We used Spearman correlation test because of the normality violation of the aggregated data. We considered a significance level of 0.05 for all the analyses. The analyses were conducted using R version 4.0.2.
RESULTS
Burden of Stroke
In 2019, the total number of DALYs attributable to overall stroke in Latin America and the Caribbean was 6 787 612.1, which represented 4.7% of the global estimate. The age‐standardized rate of DALYs for the region was 1184.7 per 100 000 habitants, which was lower than the average worldwide rate (1768.1). This burden was YLL predominant (89.5%), with YLDs contributing to only 10.5% of the number of DALYs and 8.8% to the described rate. The number of deaths attributable to stroke in LAC was 311 793 and represented 4.8% of the global deaths attributable to this condition. These absolute values indicate that the LAC region has the fourth highest burden of stroke in the world (after East Asia, Southeast Asia, and South Asia).
Country Level
When compared by absolute numbers, Brazil had the highest estimates in LAC, representing 42.2% of the total DALYs, 39.9% of the YDLs, 42.4% of YLLs, and 42.0% of the total deaths of the region, followed by Mexico and Argentina. The age‐standardized DALY rate of stroke per country ranged from 563.7 (Costa Rica) to 3593.6 (Haiti). Haiti's DALY estimate doubled globally (3593.6; 95% UI, 2437.3–5116.5), followed by Honduras, the Dominican Republic, Bolivia, Paraguay, and Brazil. Those countries also had the highest rates of YLLs and deaths. For YLDs, Uruguay, Haiti, Paraguay, the Dominican Republic, Chile, and Brazil had the highest estimates. The lowest rates of DALYs, YLLs, and deaths were found in Peru, Costa Rica, and Colombia. The lowest rates of YLDs were found in El Salvador, Peru, Guatemala, Colombia, and Honduras.
A summary of the estimates of numbers and in age‐standardized rates of DALYs, YLLs, YLDs, and deaths worldwide, in the LAC region, and in individual countries, is presented in Table S2. In addition, the geographical representation of the burden of stroke according to age‐standardized rates of the 4 metrics is displayed in Figure 1.
Figure 1.

Age‐standardized burden of stroke per 100 000 habitants in Latin America and the Caribbean during 2019.
A, Disability‐adjusted life years (DALYs). B, Years lived with disability (YLDs). C, Years of life lost (YLLs). D, Deaths. The 5 most affected countries, as measured by DALYs, YLLs, and deaths, were Haiti, the Dominican Republic, Paraguay, Bolivia, and Brazil. The 5 countries with the highest YLD burdens were Uruguay, Chile, Argentina, Haiti, and Brazil. The country with the lowest burden in the region according to DALYs, YLDs, YLLs, and deaths was Peru.
Burden of Stroke Subtypes
Intracerebral hemorrhage was the main contributor to stroke burden (42% of DALYs), as measured by absolute numbers and age‐standardized rates of DALYs and YLLs, followed by ischemic stroke (40%) and subarachnoid hemorrhage (18%). Ischemic stroke was the main contributor to YLDs and deaths (68.7% and 52.9% of LAC absolute numbers, respectively). According to age‐standardized rates, Haiti had the highest burden attributable to all stroke subtypes, followed by Honduras (for ischemic stroke and subarachnoid hemorrhage) and the Dominican Republic (for intracerebral hemorrhage). A summary of the estimates by stroke subtype in both numbers and age‐standardized rates per country is presented in Table S3. The geographical representation of stroke burden according to the 4 age‐standardized rate metrics can be found in Figures S1 through S5.
The relative contribution of the LAC stroke burdens (overall and subtypes) to the global values in absolute numbers ranged from 4.2% to 9.8%.
Age and Sex
In LAC, people aged between 50 and 75 years had the highest stroke burden, with 3 435 397 DALYs (95% UI, 2 983 856–3 980 453), representing 50.6% of DALYs (95% UI, 43.9%–58.6%); 3 096 039 YLLs (95% UI, 2 657 707–3 617 275), representing 51% of YLLs (95% UI, 43.8%–59.6%); and 339 357 YLDs (95% UI, 247 668–432 400), representing 47.7% of YLDs (95% UI, 34.8%–60.8%). People aged >75 years had the highest stroke mortality, with 167 713 deaths (95% UI, 138 108–193 262), representing 53.8% of deaths (95% UI, 44.3%–62%); followed by individuals aged between 50 and 75 years, with 120 504 deaths (95% UI, 103 500–140 522), representing 38.6% of deaths (95% UI, 33.2%–45%). In addition, people in the 50 to 75 years range accounted for the largest burden attributable to hemorrhagic and subarachnoid stroke subtypes and the second largest burden attributable to ischemic stroke. Older people (aged >75 years) accounted for the largest burden attributable to ischemic stroke.
According to sex, men contributed slightly more to the total burden of stroke in terms of DALYs (50.8% [95% UI, 43.9%–58.9%], 3 445 199 [95% UI, 2 974 238–3 996 537]). In addition, for the components of the burden, men had a higher YLL rate (52.2% [95% UI, 44.6%–61.1%], 3 171 235 [95% UI, 2 710 125–3 711 778]), whereas women had higher YLDs (61.5% [95% UI, 44.9%–78.1%], 437 032 [95% UI, 318 915–554 729]) and death rates (50.8% [95% UI, 44.3%–59.3%], 158 522 [95% UI, 132 106–185 200]). The sex distributions in LAC and globally were similar for ischemic stroke (men had higher DALY and YLL rates, whereas women had higher YLDs and mortality rates) and intracerebral hemorrhage (women had higher YLD rates). For subarachnoid hemorrhage, women accounted for a larger burden in the global estimates of YLDs and mortality than men. In LAC, women accounted for a larger burden of subarachnoid hemorrhage in all estimates (DALYs, YDLs, YLLs, and mortality).
Risk Factor Clusters
Globally and in LAC, the metabolic risk factor cluster was the main contributor to the stroke burden, at 70.97% and 70.14% DALYs, respectively. Worldwide, men had a larger attributable burden because of the behavioral risk factor cluster, whereas women had a larger burden because of the metabolic risk factor cluster. In LAC, the metabolic risk factor cluster was the largest contributor to the burden in both sexes. Men had an ≈10% larger burden attributable to the behavioral risk factor cluster than women. Globally and in LAC, the stroke burden attributable to the behavioral risk factor cluster was larger in patients aged <50 years, whereas the burden attributable to the metabolic risk factor cluster was larger in patients aged >50 years. According to income in LAC, upper‐middle income countries had the largest (67.8% DALYs) stroke burden attributable to the behavioral risk cluster, whereas high‐income countries had the smallest (34.4% DALYs). In addition, we observed that countries with lower incomes had higher risk attributable to the environmental/occupational risk factor cluster. The ranking of risk factors for total DALYs attributable to overall stroke according to country, income classification, sex, and age is presented in Figure 2.
Figure 2.

Stroke risk factor rankings and population‐attributable fractions of high systolic blood pressure (SBP) and high body mass index (BMI) in Latin America and the Caribbean.
A, Individual risk factors ranked by number of disability‐adjusted life years (DALYs) attributable to overall stroke in 2019. B, Risk attributable to high SBP for overall stroke. C, Risk attributable to high BMI for overall stroke. LDL indicates low‐density lipoprotein.
Metabolic risk factors were the principal contributors in all stroke subtypes globally and in LAC and were not affected by sex or age. People aged <50 years had a larger burden attributable to behavioral risk factors than metabolic risk factors. This trend was prominent in upper‐middle income countries. On the other hand, people aged >50 years had a larger burden attributable to metabolic risk factors. This trend was not affected by country income.
PAFs of Individual Risk Factors
In LAC, high SBP was the leading risk factor in all countries, except Bolivia and Ecuador. In those countries, the leading cause was high BMI, which was the second leading cause in most LAC countries. The percentage of DALYs attributable to high SBP was 53%. This means that if controlled, the total number of DALYs would decrease from 6 787 612 to 3 157 022. Similarly, the percentage of DALYs attributable to high BMI was 37%, indicating that if controlled, DALYs would be reduced to 4 298 890. These values suggest that DALYs attributable to stroke could be reduced by up to 90% by controlling only these 2 main modifiable risk factors. Similar patterns were found for YLDs, YLLs, and mortality (Table S4). According to stroke subtypes, SBP and BMI control could particularly reduce the hemorrhagic stroke and subarachnoid hemorrhage burdens (up to a 98% DALY reduction) (Table S5).
High fasting plasma glucose, smoking, and ambient particulate matter pollution exposure were the following highest ranked risks in LAC (Figure 2). Household air pollution from solid fuels was among the top 5 risk factors in lower‐middle and low‐income countries.
Globally and in LAC, high SBP was the main individual risk factor for all stroke subtypes. The rankings of risk factors by stroke subtype are presented in Figures S4 to S6.
Correlations
No significant correlation was found between total DALYs and SDI or between SDI and risk factor PAFs after adjustments for sex and age.
DISCUSSION
Main Findings
According to the GBD study collaborators, regional‐ and country‐level subanalyses of GBD study data are encouraged to explore and understand trends of disease dynamics to establish priorities for interventions. 19 Nevertheless, comprehensive burden assessments at the regional level in LAC remain scarce. 20 To the best of our knowledge, this is the first assessment of the stroke burden in LAC. We organized a hierarchy of stroke risk factors according to country and stroke subtype. That information was not available directly from the GBD study platform and was the result of extensive data extraction, data cleansing, and processing in the current study.
In 2019, LAC had the fourth largest burden of stroke globally (≈6.8 million absolute DALYs). This is predominantly attributable to premature deaths, representing ≈90% of the burden. Intracerebral hemorrhage was the main contributor to DALYs, YLLs, and deaths, but ischemic stroke was the main cause of disability (69% of all YLDs). Older adults and men had the largest stroke burdens, whereas women had the highest disability rate.
Finally, metabolic factors were the most important risk factors. Interestingly, up to 90% of the burden could be reduced by targeting 2 modifiable factors: high SBP (53%) and BMI (37%). Overall, these results are aligned with those previously reported globally. 2 , 3 However, the potential burden reduction in LAC is larger than the global estimation, 3 with a particular benefit to the hemorrhagic stroke burden. Our results underscore the need for integrated national strategies for stroke awareness and prevention in LAC.
Country‐Level Findings
Haiti, Honduras, and the Dominican Republic were the most affected countries in the region in terms of density of age‐standardized rates per 100 000 inhabitants. Haiti had double the global stroke burden density and was among the top 5 countries with the highest YLDs for all stroke subtypes, except for subarachnoid hemorrhage, for which it had the lowest burden. This suggests that in Haiti, a small number of patients survive after subarachnoid hemorrhage. This could likely be explained by their weak health care system and limited resources, which reduce the effectiveness of preventive and therapeutic policies. 21 In the case of hemorrhagic stroke, which has greater severity and a higher risk of mortality than ischemic stroke, 22 positive outcomes rely on specialized intensive care. 23 , 24 , 25 Intensive care units are scarce and poorly equipped in Haiti, 26 and accessibility to high‐quality primary care services is limited for most of the population. 27 Education about what to do when someone presents common stroke symptoms via the primary care system is key to mitigating or decreasing the modifiable risk factors associated with hemorrhagic stroke. 28 , 29 , 30 High‐income countries, such as Uruguay and Chile, had the largest age‐standardized YLD values for stroke and all its subtypes, suggesting a large number of survivors with some type of disability and a potential lack of a systematic poststroke rehabilitation program. 1
Sources of Burden Heterogeneity
It has been reported that male individuals and older adults are more likely to be affected by stroke and related sequelae 4 , 31 , 32 ; however, our results showed that women in LAC had a larger burden of subarachnoid hemorrhage in 2019 than global values. In addition, metabolic risk factors were predominant in women and in people aged >50 years, whereas behavioral risk factors were predominant in men and people aged <50 years. It has been reported that stroke outcomes vary according to socioeconomic status 33 and that stroke risk and mortality in developing countries could be associated with socioeconomic status. 34 Nevertheless, our results did not show any correlation between the socioeconomic development level and stroke burden in LAC. This could be explained by the epidemiological transitions of some LAC countries or by the fact that socioeconomic development is not necessarily associated with appropriate allocation toward health care.
Stroke Risk Factors in LAC
LAC is a multicultural geographic region that has several other potential risk factors, some of which (ethnic and cultural factors) were not assessed in the GBD study. 35 However, similar to the results of previous studies in the region, 36 our results showed that most of the attributable risk factors for stroke were modifiable. High SBP was the primary contributor, followed by high BMI, similar to the global estimations. However, the PAF in LAC was higher (90%) than that worldwide (<80%). 3 The relationship between these 2 factors and cardiovascular disease and stroke has already been established, 37 but preventive strategies have not yet been successfully implemented. Reducing salt intake remains one of the most relevant interventions. 38 In addition, community‐based multicomponent interventions are potential solutions in need of testing.
Smoking is an important risk factor in the region despite previous efforts by certain countries to establish smoke‐free policies. 39 Smoke‐free policies have been indicated to be successful in reducing the frequency of smoking and its cardiovascular consequences. 36 , 40 , 41 Stronger smoke‐free measures should be established and implemented throughout the region.
Environmental risk factors have increased worldwide, especially in limited‐resource settings. As in LAC, countries with low and middle incomes have higher disease burdens associated with environmental risk factors compared with high‐income countries. 36 Future studies need to explore the effect of ambient pollution on stroke in LAC, especially in countries with intense mining activities and constant vehicle fleet growth.
Implications for Public Health Practice and Research
According to our findings, the most important modifiable risk factors for stroke were elevated SBP, high BMI, smoking, and environmental factors. Primary prevention policies to address chronic conditions have been proven to be cost‐efficient for the health care system 42 and to reduce the stroke burden at the individual level. 29 Some measures, such as the labeling of processed food to reduce salt intake, 43 governmental control agreements for processed food and product labeling to reduce trans‐fatty acid consumption, 44 , 45 and incremental tobacco taxation 46 and restriction of smoking areas 47 for reducing smoking, have been proven to be useful in resource‐constrained settings. 48 Instruments for the evaluation of such interventions have been proposed and are useful for producing standardized national reports on stroke risk factors. 49
At the country level, national programs should target control of high SBP (>115 mm Hg) and BMI (>25 kg/m2), which are the 2 most important risk factors. In LAC, there has been evidence of the success of multicomponent programs focused on self‐registration of blood pressure, healthy food consumption, reduction in salt, and physical activity. 50 , 51 However, those were focal efforts without continuity. Mobile telephone‐based interventions could be useful for promoting weight loss and increasing physical activity. 52 , 53 For the early detection and treatment of stroke, educational interventions about initial symptoms and access to care are fundamental. Many tools have been tested, such as video lessons, information presentations, and even one‐on‐one counseling, but their efficacy was moderate, and most of them were conducted in developed countries. 54 In Argentina, an 18‐month primary care intervention in a low‐resource setting significantly reduced blood pressure values and was cost‐effective. This randomized controlled cluster trial included physician‐guided education, a community health care provider component (health coaching and home blood pressure monitoring and audit), blood pressure feedback, and tailored text messages. 55 The protective effects and cost‐effectiveness related to cardiovascular risks and stroke were sustained long‐term. 56 Multinational collaboration and coordinated efforts are needed to implement similar programs in primary care systems across LACs.
Standardized evaluations of the burden of neuropsychiatric diseases at regional levels are scarce. 20 , 57 , 58 In addition to the global stroke estimation, 2 estimations for Europe, Mexico, Brazil, and China have been updated. 59 , 60 , 61 , 62 In Europe, the age‐standardized DALY rate was 1340 per 100 000 habitants, 62 which was slightly higher than our estimate (1184.7) but lower than the global estimate (1768.1). 2 However, mortality was higher in LAC than in Europe. China had higher age‐standardized DALY rates (2412.5 per 100 000 habitants) 59 compared with global and LAC estimates, confirming the predominant stroke burden in the South Asia region. 2 All the regional analyses, including ours, were in accordance with the global trends of larger burdens in men and older adults. For stroke subtypes, global and Chinese reports showed that intracerebral hemorrhage had the highest burden, as in our study. 2 , 59 However, ischemic stroke was the main contributor to the age‐standardized DALY rates in Mexico and Brazil. 60 , 61 A European analysis did not report estimates by stroke subtype. Finally, a global study reported high SBP, high BMI, and smoking as the top risk factors. In China, the most important risk factors were high SBP, ambient particulate matter pollution exposure, and smoking. In LAC, the pattern was similar to the global pattern, with high SBP and high BMI being the top risk factors.
A systematic review including studies from high‐income countries and regions (the United Kingdom, United States, Canada, Australia, and Scandinavia) and Iran concluded that the perception of patients with stroke and caregivers toward training on identifying early signs and symptoms of stroke provided by primary health care providers was a weak link in the treatment chain. Poststroke patients reported feeling that their primary care physicians and health care providers did not provide appropriate management for prompt recovery. 63 These primary studies were not conducted in LAC and support our argument that this is a worldwide issue. In addition, in many countries in LAC, primary care or preventive care is not a role assumed by physicians but by other health care professionals or health care workers, and it is a less used component of the health system. Moreover, physicians have admitted that many barriers (infrastructure, professional competencies, and patients' awareness and beliefs) limit them in providing evidence‐based care for their patients. 64 Finally, the use of telemedicine for stroke, as recommended by the American Heart Association/American Stroke Association stroke guidelines, 65 is limited by access to digital health technologies in LAC. 66 However, the current COVID‐19 pandemic, which has initiated telemedicine reform, could make this approach more feasible in the region. 67
Further research is needed to evaluate and develop context‐tailored interventions for modifiable stroke risk factors to reduce the stroke burden in LAC. 1 There is much need for improvement, as the interplay of multidimensional social, economic, and political aspects creates a unique set of challenges in LAC.
Limitations
This was a secondary analysis, and the quality of the results was dependent on the quality of the primary information (GBD study data). As stated, certain countries had scarce data and relied on epidemiological prediction models. Other countries, especially in the Caribbean, still lack primary data, preventing us from performing a full regional assessment. Finally, there is a need to improve the national registration of diseases. This would prevent underdiagnosis or misclassification of stroke and its subtypes. Thus, these estimates should be interpreted with caution, especially those with the lowest rates in the region because of potential underreporting.
CONCLUSIONS
In summary, in 2019, the LAC region had the fourth largest stroke burden worldwide, predominantly attributable to premature deaths (≈90% of the total burden). Intracerebral hemorrhage was the main contributor to this burden, but ischemic stroke was the main cause of disability. Within LAC, the distribution of the burden of stroke was heterogeneous. Developed and developing LAC countries experience similar stroke burdens. Metabolic risk factors (high SBP and high BMI) were the main contributors to the overall stroke burden and its subtypes. These modifiable risk factors make stroke a highly preventable disease in the region. Investment in primary prevention should be a public health priority. Multinational stroke awareness campaigns for prompt recognition, screening of comorbidities, and education about healthy lifestyles might be effective in reducing the burden of stroke and its associated high‐cost impact.
Sources of Funding
None.
Disclosures
None.
Supporting information
Tables S1–S5
Figures S1–S6
For Sources of Funding and Disclosures, see page 9.
Supplemental Material for this article is available at https://www.ahajournals.org/doi/suppl/10.1161/JAHA.122.027044
Contributor Information
Kevin Pacheco‐Barrios, Email: kevin.pacheco.barrios@gmail.com.
Carlos Alva‐Diaz, Email: alvacarl@crece.uss.edu.pe.
References
- 1. Martins SCO, Sacks C, Hacke W, Brainin M, de Assis FF, Pontes‐Neto OM, Germain PML, Marinho MF, Wiegering AH, McGhie DV. Priorities to reduce the burden of stroke in Latin American countries. Lancet Neurol. 2019;18:674–683. doi: 10.1016/S1474-4422(19)30068-7 [DOI] [PubMed] [Google Scholar]
- 2. Feigin VL, Stark BA, Johnson CO, Roth GA, Bisignano C, Abady GG, Abbasifard M, Abbasi‐Kangevari M, Abd‐Allah F, Abedi V. Global, regional, and national burden of stroke and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Neurol. 2021;20:795–820. doi: 10.1016/S1474-4422(21)00252-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3. GBD 2016 Stroke Collaborators . Global, regional, and national burden of stroke, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2019;18:439–458. doi: 10.1016/S1474-4422(19)30034-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4. Ferri CP, Schoenborn C, Kalra L, Acosta D, Guerra M, Huang Y, Jacob K, Rodriguez JJL, Salas A, Sosa AL. Prevalence of stroke and related burden among older people living in Latin America, India and China. J Neurol Neurosurg Psychiatry. 2011;82:1074–1082. doi: 10.1136/jnnp.2010.234153 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5. CDC . Stroke Facts|cdc.gov. Available at: https://www.cdc.gov/stroke/facts.htm
- 6. James SL, Abate D, Abate KH, Abay SM, Abbafati C, Abbasi N, Abbastabar H, Abd‐Allah F, Abdela J, Abdelalim A, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392:1789–1858. doi: 10.1016/S0140-6736(18)32279-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7. Ritchie M, Roser H. Burden of disease. OurWorldInData.org. 2021.
- 8. WHO . Global health estimates: life expectancy and leading causes of death and disability. Geneva, Switzerland: World Health Organization; 2021. [Google Scholar]
- 9. IHME . About GBD|Institute for health metrics and evaluation. Available at: http://www.healthdata.org/gbd/about.
- 10. Roth GA, Abate D, Abate KH, Abay SM, Abbafati C, Abbasi N, Abbastabar H, Abd‐Allah F, Abdela J, Abdelalim A, et al. Global, regional, and national age‐sex‐specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392:1736–1788. doi: 10.1016/s0140-6736(18)32203-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11. Aho K, Harmsen P, Hatano S, Marquardsen J, Smirnov V, Strasser T. Cerebrovascular disease in the community: results of a WHO Collaborative Study. Bull World Health Organ. 1980;58:113–130. [PMC free article] [PubMed] [Google Scholar]
- 12. Worldometer . Countries in Latin America and the Caribbean. Available at: https://www.worldometers.info/geography/how‐many‐countries‐in‐latin‐america/. Accessed April 28, 2021.
- 13. Global Burden of Disease . GBD 2015 geographies. Available at: https://www.who.int/choice/demography/regions/en/. Accessed April 28, 2021.
- 14. GBD 2019 Diseases and Injuries Collaborators . Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396:1204–1222. doi: 10.1016/s0140-6736(20)30925-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15. Reisner A, Chern JJ, Grattan‐Smith JD, Gary MF, Palasis S, Little SB. Letter: Surfer's myelopathy: a rare form of spinal cord infarction in novice surfers: a systematic review. Neurosurgery. 2017;80:E213. doi: 10.1093/neuros/nyw104 [DOI] [PubMed] [Google Scholar]
- 16. Lopez AD, Mathers C, Ezzati M, Jamison D, Cjl M. The burden of disease and mortality by condition: data, methods, and results for 2001. In: The World Bank , ed Global Burden of Disease and Risk FactorsThe International Bank for Reconstruction and Development. New York: Oxford University Press; 2006:45–48. [PubMed] [Google Scholar]
- 17. GBD 2019 Risk Factors Collaborators . Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396:1223–1249. doi: 10.1016/s0140-6736(20)30752-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18. GBD 2016 Risk Factors Collaborators . Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390:1345–1422. doi: 10.1016/s0140-6736(17)32366-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19. Vos T, Allen C, Arora M, Barber RM, Bhutta ZA, Brown A, Carter A, Casey DC, Charlson FJ, Chen AZ. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388:1545–1602. doi: 10.1016/S0140-6736(16)31678-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20. Pacheco‐Barrios K, Navarro‐Flores A, Cardenas‐Rojas A, de Melo PS, Uygur‐Kucukseymen E, Alva‐Diaz C, Fregni F, Burneo JG. Burden of epilepsy in Latin America and The Caribbean: a trend analysis of the Global Burden of Disease Study 1990–2019. Lancet Reg Health Am. 2022;8:100140. doi: 10.1016/j.lana.2021.100140 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21. Fene F, Gómez‐Dantés O, Lachaud J. Haitian health system. Salud Publica Mex. 2020;62:298–305. doi: 10.21149/10938 [DOI] [PubMed] [Google Scholar]
- 22. Andersen KK, Olsen TS, Dehlendorff C, Kammersgaard LP. Hemorrhagic and ischemic strokes compared. Stroke. 2009;40:2068–2072. doi: 10.1161/strokeaha.108.540112 [DOI] [PubMed] [Google Scholar]
- 23. Diringer MN, Edwards DF. Admission to a neurologic/neurosurgical intensive care unit is associated with reduced mortality rate after intracerebral hemorrhage. Crit Care Med. 2001;29:635–640. doi: 10.1097/00003246-200103000-00031 [DOI] [PubMed] [Google Scholar]
- 24. Terént A, Asplund K, Farahmand B, Henriksson KM, Norrving B, Stegmayr B, Wester PO, Asberg KH, Asberg S. Stroke unit care revisited: who benefits the most? A cohort study of 105,043 patients in riks‐stroke, the Swedish stroke register. J Neurol Neurosurg Psychiatry. 2009;80:881–887. doi: 10.1136/jnnp.2008.169102 [DOI] [PubMed] [Google Scholar]
- 25. Stroke Unit Trialists' Collaboration . Organised inpatient (stroke unit) care for stroke. Cochrane Database Syst Rev. 2013;2013:CD000197. doi: 10.1002/14651858.CD000197.pub3 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26. Losonczy LI, Barnes SL, Liu S, Williams SR, McCurdy MT, Lemos V, Chandler J, Colas LN, Augustin ME, Papali A. Critical care capacity in Haiti: a nationwide cross‐sectional survey. PLoS One. 2019;14:e0218141. doi: 10.1371/journal.pone.0218141 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27. Gage AD, Leslie HH, Bitton A, Jerome JG, Thermidor R, Joseph JP, Kruk ME. Assessing the quality of primary care in Haiti. Bull World Health Organ. 2017;95:182–190. doi: 10.2471/BLT.16.179846 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28. Shafei R. Stroke prevention in primary care. J Neurol Neurosurg Psychiatry. 2012;83:A2A2. doi: 10.1136/jnnp-2012-304200a.10 [DOI] [Google Scholar]
- 29. Pandian JD, Gall SL, Kate MP, Silva GS, Akinyemi RO, Ovbiagele BI, Lavados PM, Gandhi DBC, Thrift AG. Prevention of stroke: a global perspective. Lancet. 2018;392:1269–1278. doi: 10.1016/S0140-6736(18)31269-8 [DOI] [PubMed] [Google Scholar]
- 30. Soljak M, Calderon‐Larrañaga A, Sharma P, Cecil E, Bell D, Abi‐Aad G, Majeed A. Does higher quality primary health care reduce stroke admissions? A national cross‐sectional study. Br J Gen Pract. 2011;61:e801–e807. doi: 10.3399/bjgp11X613142 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31. Benjamin EJ, Virani SS, Callaway CW, Chamberlain AM, Chang AR, Cheng S, Chiuve SE, Cushman M, Delling FN, Deo R. Heart disease and stroke statistics—2018 update: a report from the American Heart Association. Circulation. 2018;137:e67–e492. doi: 10.1161/CIR.0000000000000573 [DOI] [PubMed] [Google Scholar]
- 32. Bensenor IM, Goulart AC, Szwarcwald CL, Vieira MLFP, Malta DC, Lotufo PA. Prevalence of stroke and associated disability in Brazil: national health survey‐2013. Arq Neuropsiquiatr. 2015;73:746–750. doi: 10.1590/0004-282X20150115 [DOI] [PubMed] [Google Scholar]
- 33. Lavados PM, Hennis AJ, Fernandes JG, Medina MT, Legetic B, Hoppe A, Sacks C, Jadue L, Salinas R. Stroke epidemiology, prevention, and management strategies at a regional level: Latin America and the Caribbean. Lancet Neurol. 2007;6:362–372. doi: 10.1016/S1474-4422(07)70003-0 [DOI] [PubMed] [Google Scholar]
- 34. Wu SH, Woo J, Zhang X‐H. Worldwide socioeconomic status and stroke mortality: an ecological study. Int J Equity Health. 2013;12:1–11. doi: 10.1186/1475-9276-12-42 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35. Avezum Á, Costa‐Filho FF, Pieri A, Martins SO, Marin‐Neto JA. Stroke in Latin America: burden of disease and opportunities for prevention. Glob Heart. 2015;10:323–331. doi: 10.1016/j.gheart.2014.01.006 [DOI] [PubMed] [Google Scholar]
- 36. Feigin VL, Roth GA, Naghavi M, Parmar P, Krishnamurthi R, Chugh S, Mensah GA, Norrving B, Shiue I, Ng M. Global burden of stroke and risk factors in 188 countries, during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet Neurol. 2016;15:913–924. doi: 10.1016/S1474-4422(16)30073-4 [DOI] [PubMed] [Google Scholar]
- 37. World Health Organization . Regional Strategy on an Integrated Approach to the Prevention and Control of Chronic Diseases Including Diet, Physical Activity, and Health. Geneva, Switzerland: World Health Organization; 2006. [Google Scholar]
- 38. He FJ, Tan M, Ma Y, MacGregor GA. Salt reduction to prevent hypertension and cardiovascular disease: JACC state‐of‐the‐art review. J Am Coll Cardiol. 2020;75:632–647. doi: 10.1016/j.jacc.2019.11.055 [DOI] [PubMed] [Google Scholar]
- 39. Sebrié EM, Schoj V, Travers MJ, McGaw B, Glantz SA. Smokefree policies in Latin America and the Caribbean: making progress. Int J Environ Res Public Health. 2012;9:1954–1970. doi: 10.3390/ijerph9051954 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40. Ferrante D, Linetzky B, Virgolini M, Schoj V, Apelberg B. Reduction in hospital admissions for acute coronary syndrome after the successful implementation of 100% smoke‐free legislation in Argentina: a comparison with partial smoking restrictions. Tob Control. 2012;21:402–406. doi: 10.1136/tc.2010.042325 [DOI] [PubMed] [Google Scholar]
- 41. Sebrié EM, Sandoya E, Hyland A, Bianco E, Glantz SA, Cummings KM. Hospital admissions for acute myocardial infarction before and after implementation of a comprehensive smoke‐free policy in Uruguay. Tob Control. 2013;22:e16–e20. doi: 10.1136/tobaccocontrol-2011-050134 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42. Cohen JT, Neumann PJ, Weinstein MC. Does preventive care save money? Health economics and the presidential candidates. N Engl J Med. 2008;358:661–663. doi: 10.1056/NEJMp0708558 [DOI] [PubMed] [Google Scholar]
- 43. Smith‐Spangler CM, Juusola JL, Enns EA, Owens DK, Garber AM. Population strategies to decrease sodium intake and the burden of cardiovascular disease: a cost‐effectiveness analysis. Ann Intern Med. 2010;152(481–487):w170–w483. doi: 10.7326/0003-4819-152-8-201004200-00212 [DOI] [PubMed] [Google Scholar]
- 44. Colón‐Ramos U, Lindsay AC, Monge‐Rojas R, Greaney ML, Campos H, Peterson KE. Translating research into action: a case study on trans fatty acid research and nutrition policy in Costa Rica. Health Policy Plan. 2007;22:363–374. doi: 10.1093/heapol/czm030 [DOI] [PubMed] [Google Scholar]
- 45. Pérez‐Ferrer C, Lock K, Rivera JA. Learning from international policies on trans fatty acids to reduce cardiovascular disease in low‐ and middle‐income countries, using Mexico as a case study. Health Policy Plan. 2010;25:39–49. doi: 10.1093/heapol/czp040 [DOI] [PubMed] [Google Scholar]
- 46. Guindon GE, Paraje GR, Chaloupka FJ. The impact of prices and taxes on the use of tobacco products in Latin America and the Caribbean. Rev Panam Salud Publica. 2016;40:272–284. [PubMed] [Google Scholar]
- 47. Woolery T, Asma S, Sharp D. Clean indoor‐air laws and youth access. In: Jha P, Chaloupka FJ, eds Tobacco Control in Developing Countries. Oxford: Oxford University Press; 2000:273–286. [Google Scholar]
- 48. Gaziano TA, Pagidipati N. Scaling up chronic disease prevention interventions in lower‐ and middle‐income countries. Annu Rev Public Health. 2013;34:317–335. doi: 10.1146/annurev-publhealth-031912-114402 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49. World Health Organization . WHO steps stroke manual: the WHO STEPwise approach to stroke surveillance. Geneva, Switzerland: World Health Organization; 2005. [Google Scholar]
- 50. Kim JK, Jo HY, Malo MA, Nam EW. Effectiveness of a comprehensive blood pressure control program in primary health care in Peru. Rev Panam Salud Publica. 2020;44:e18. doi: 10.26633/rpsp.2020.18 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51. Mazzaro CC, Klostermann FC, Erbano BO, Schio NA, Guarita‐Souza LC, Olandoski M, Faria‐Neto JR, Baena CP. Dietary interventions and blood pressure in Latin America – systematic review and meta‐analysis. Arq Bras Cardiol. 2014;102:345–354. doi: 10.5935/abc.20140037 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52. Rubinstein A, Miranda JJ, Beratarrechea A, Diez‐Canseco F, Kanter R, Gutierrez L, Bernabé‐Ortiz A, Irazola V, Fernandez A, Letona P, et al. Effectiveness of an mHealth intervention to improve the cardiometabolic profile of people with prehypertension in low‐resource urban settings in Latin America: a randomised controlled trial. Lancet Diabetes Endocrinol. 2016;4:52–63. doi: 10.1016/s2213-8587(15)00381-2 [DOI] [PubMed] [Google Scholar]
- 53. Toro‐Ramos T, Kim Y, Wood M, Rajda J, Niejadlik K, Honcz J, Marrero D, Fawer A, Michaelides A. Efficacy of a mobile hypertension prevention delivery platform with human coaching. J Hum Hypertens. 2017;31:795–800. doi: 10.1038/jhh.2017.69 [DOI] [PubMed] [Google Scholar]
- 54. Gardois P, Booth A, Goyder E, Ryan T. Health promotion interventions for increasing stroke awareness in ethnic minorities: a systematic review of the literature. BMC Public Health. 2014;14:409. doi: 10.1186/1471-2458-14-409 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55. He J, Irazola V, Mills KT, Poggio R, Beratarrechea A, Dolan J, Chen C‐S, Gibbons L, Krousel‐Wood M, Bazzano LA, et al. Effect of a community health worker–led multicomponent intervention on blood pressure control in low‐income patients in Argentina: a randomized clinical trial. JAMA. 2017;318:1016–1025. doi: 10.1001/jama.2017.11358 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56. Zhang Y, Yin L, Mills K, Chen J, He J, Palacios A, Riviere AP, Irazola V, Augustovski F, Shi L. Cost‐effectiveness of a multicomponent intervention for hypertension control in low‐income settings in Argentina. JAMA Network Open 2021;4:e2122559. doi: 10.1001/jamanetworkopen.2021.22559 %J JAMA Network Open [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57. Alva‐Díaz C, Huerta‐Rosario A, Pacheco‐Barrios K, Molina RA, Navarro‐Flores A, Aguirre‐Quispe W, Custodio N, Toro‐Perez J, Mori N, Romero‐Sanchez R. Neurological diseases in Peru: a systematic analysis of the global burden disease study. Arq Neuro Psiquiatr. 2020;78:282–289. doi: 10.1590/0004-282x20200018 [DOI] [PubMed] [Google Scholar]
- 58. Alva‐Diaz C, Huerta‐Rosario A, Molina RA, Pacheco‐Barrios K, Aguirre‐Quispe W, Navarro‐Flores A, Velásquez‐Rimachi V, Sinche‐Espinal HA, Ocampo‐Zegarra JC, Andamayo‐Villalba LA, et al. Mental and substance use disorders in Peru: a systematic analysis of the global burden of disease study. J Public Health. 2020;1–10:629–638. doi: 10.1007/s10389-020-01341-9 [DOI] [Google Scholar]
- 59. Ma Q, Li R, Wang L, Yin P, Wang Y, Yan C, Ren Y, Qian Z, Vaughn MG, McMillin SE, et al. Temporal trend and attributable risk factors of stroke burden in China, 1990–2019: an analysis for the Global Burden of Disease Study 2019. Lancet Public Health. 2021;6:e897–e906. doi: 10.1016/s2468-2667(21)00228-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60. de Santana NM, Dos Santos Figueiredo FW, de Melo Lucena DM, Soares FM, Adami F, de Carvalho Pádua Cardoso L, Correa JA. The burden of stroke in Brazil in 2016: an analysis of the Global Burden of Disease study findings. BMC Res Notes. 2018;11:735. doi: 10.1186/s13104-018-3842-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61. Cruz‐Góngora VDL, Chiquete E, Gómez‐Dantés H, Cahuana‐Hurtado L, Cantú‐Brito C. Trends in the burden of stroke in Mexico: a national and subnational analysis of the global burden of disease 1990–2019. Lancet Reg Health Am. 2022;10:100204. doi: 10.1016/j.lana.2022.100204 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62. Wafa HA, Wolfe CDA, Emmett E, Roth GA, Johnson CO, Wang Y. Burden of stroke in Europe. Stroke. 2020;51:2418–2427. doi: 10.1161/strokeaha.120.029606 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 63. Pindus DM, Mullis R, Lim L, Wellwood I, Rundell AV, Aziz NAA, Mant J. Stroke survivors' and informal caregivers' experiences of primary care and community healthcare services—a systematic review and meta‐ethnography. PLoS One. 2018;13:e0192533. doi: 10.1371/journal.pone.0192533 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 64. Baatiema L, Otim ME, Mnatzaganian G, de‐Graft Aikins A, Coombes J, Somerset S. Health professionals' views on the barriers and enablers to evidence‐based practice for acute stroke care: a systematic review. Implement Sci. 2017;12:74. doi: 10.1186/s13012-017-0599-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 65. Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K, Biller J, Brown M, Demaerschalk BM, Hoh B, et al. Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2019;50:e344–e418. doi: 10.1161/str.0000000000000211 [DOI] [PubMed] [Google Scholar]
- 66. Curioso WH. Building capacity and training for digital health: challenges and opportunities in Latin America. J Med Internet Res. 2019;21:e16513. doi: 10.2196/16513 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 67. Montenegro P, Pinillos L, Young F, Aguilar A, Tirado‐Hurtado I, Pinto JA, Vallejos C. Telemedicine and the current opportunities for the management of oncological patients in Peru in the context of COVID‐19 pandemic. Crit Rev Oncol Hematol. 2021;157:103129. doi: 10.1016/j.critrevonc.2020.103129 [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Tables S1–S5
Figures S1–S6
